Press release
Rising Prevalence Of Chronic Diseases Fuels Growth In The Duchenne Muscular Dystrophy Market: A Key Catalyst Accelerating Duchenne Muscular Dystrophy Market Growth in 2025
Duchenne Muscular Dystrophy
What Will the Duchenne Muscular Dystrophy Industry Market Size Be by 2025?
The market for Duchenne muscular dystrophy has seen a robust growth in the past few years. The market is projected to expand from $1.16 billion in 2024 to $1.26 billion in 2025, with a compound annual growth rate (CAGR) of 8.9%. The growth during the historical period is credited to advancements in genetic comprehension and diagnosis, progression in clinical trials, increased patient advocacy and awareness, incentives and recognition for orphan drugs, and joint research initiatives.
What's the Long-Term Growth Forecast for the Duchenne Muscular Dystrophy Market Size Through 2029?
Expectations are high for a substantial expansion in the duchenne muscular dystrophy market in the coming years, with projections indicating it will reach $1.75 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 8.5%. The predicted surge during the forecast period is predominantly due to ongoing developments in gene therapies, precision medicine strategies, greater access to treatments, continuous long-term research and regulatory improvements. The forecast period is likely to witness certain trends such as the adoption of digital health technologies, advancements in therapeutic technologies, gene therapies and genetic medicines, regulatory endorsement for orphan drugs and precision medicine methodologies.
View the full report here:
https://www.thebusinessresearchcompany.com/report/duchenne-muscular-dystrophy-global-market-report
What Are the Key Growth Drivers Fueling the Duchenne Muscular Dystrophy Market Expansion?
The upward trend in chronic diseases is anticipated to boost the expansion of the Duchenne muscular dystrophy market in the coming years. Chronic diseases are health ailments or conditions with prolonged symptoms that endure for a minimum of one year. Duchenne muscular dystrophy fulfills the particular therapeutic demands of people suffering from this genetic affliction, underscoring the larger importance of personalized medicine in managing and potentially reducing the consequences of chronic conditions. To illustrate, in January 2023, the National Library of Medicine, a United States government agency, predicted that the quantity of US individuals aged 50 and above with at least one chronic condition will escalate to 142.66 million by 2050. Consequently, the growing incidence of chronic diseases is fuelling the Duchenne muscular dystrophy market's growth.
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10368&type=smp
What Are the Key Trends Driving Duchenne Muscular Dystrophy Market Growth?
Duchenne muscular dystrophy market's leading businesses are innovating with techniques like clinical trial design, enhancing drug development efficiency & effectiveness, improving patient outcomes and speeding up approval for novel therapies. The process of clinical trial design involves outlining a clinical study to assess new treatment efficacy and safety. It includes setting objectives, choosing participants, and developing methods & analyses. For example, in March 2024, the Critical Path Institute (C-Path), a non-profit based in the US, introduced the DMD Clinical Trial Simulator (CTS). The Duchenne Regulatory Science Consortium of C-Path developed this advanced tool to refine DMD therapy efficacy studies' layout. The CTS has notable elements, such as advanced modeling of functional test performance, the ability to simulate various circumstances, enhanced efficiency in trial design, and public accessibility through the C-Path website and Rare Disease Cures Accelerator-Data and Analytics Platform (RDCA-DAP). Consequently, it stands as a crucial resource for pharmaceutical companies and researchers immersed in DMD study.
How Is the Duchenne Muscular Dystrophy Market Segmented?
The duchenne muscular dystrophy market covered in this report is segmented -
1) By Therapy: Mutation Suppression, Exon Skipping Approach
2) By Therapeutic Class: Molecular Based Therapies, Steroid Therapy
3) By Route Of Administration: Oral, Parenteral, Other Routes Of Administration
4) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy
5) By End User: Hospitals, Homecare, Specialty Clinics, Other End-Users
Subsegments:
1) By Mutation Suppression: Antisense Oligonucleotides (ASOs), Small Molecules, Gene Therapy
2) By Exon Skipping Approach: Exon-Skipping Therapies, Combination Therapies, Clinical Trials And Investigational Drugs
Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=10368&type=smp
Which Companies Are Leading the Charge in Duchenne Muscular Dystrophy Market Innovation?
Major companies operating in the duchenne muscular dystrophy market include Pfizer Inc., GlaxoSmithKline plc, PerkinElmer Inc., BioMarin Pharmaceutical Inc., Sarepta Therapeutics Inc., PTC Therapeutics Inc., Asklepios BioPharmaceutical Inc., Catabasis Pharmaceuticals Inc., Wave Life Sciences Ltd., Bristol Myers Squibb Company, BridgeBio Pharma Inc., Rocket Pharmaceuticals Inc., Italfarmaco SpA, Solid Biosciences Inc., Avidity Biosciences Inc., Fulcrum Therapeutics Inc., Akashi Therapeutics Inc., WAVE Life Sciences Ltd., Capricor Therapeutics Inc., Santhera Pharmaceuticals Holding, Armagen Technologies Inc., Dyne Therapeutics Inc., Benitec Biopharma Limited, Edgewise Therapeutics Inc.
Which Regions Are Leading the Global Duchenne Muscular Dystrophy Market in Revenue?
North America was the largest region in the Duchenne muscular dystrophy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global duchenne muscular dystrophy market during the forecast period. The regions covered in the duchenne muscular dystrophy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10368
This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Rising Prevalence Of Chronic Diseases Fuels Growth In The Duchenne Muscular Dystrophy Market: A Key Catalyst Accelerating Duchenne Muscular Dystrophy Market Growth in 2025 here
News-ID: 4111076 • Views: …
More Releases from The Business Research Company
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future.
Market Valuation and Expansion Forecast for Personalized Testing…
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry.
Projected Expansion in the Skin…
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory.
Steady Growth Expected in Upadacitinib Market Size Through 2029
The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual…
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field.
Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics…
More Releases for Duchenne
Duchenne Muscular Dystrophy (DMD) Market Growth in 2034
Market Overview
The Duchenne Muscular Dystrophy (DMD) Market is expanding rapidly as advances in genetic medicine, exon-skipping therapies, gene therapy platforms, and improved diagnostic capabilities reshape treatment options for this severe, progressive neuromuscular disorder.
DMD is caused by mutations in the dystrophin gene, leading to muscle degeneration beginning in early childhood. Growing awareness among clinicians and caregivers, widespread adoption of next-generation sequencing (NGS), and increasing availability of disease-modifying therapies have significantly strengthened…
Duchenne Muscular Dystrophy: Core Growth Enabler in the Rising Prevalence Of Chr …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Duchenne Muscular Dystrophy Industry Market Size Be by 2025?
The market size for Duchenne Muscular Dystrophy has shown significant expansion recently, burgeoning from $1.16 billion in 2024 to $1.25 billion in 2025 at a compound annual growth rate (CAGR) of 7.9%. The impressive growth in the…
Shaping the Duchenne Muscular Dystrophy (DMD) Therapeutics Market in 2025: Bit B …
How Big Is the Duchenne Muscular Dystrophy (DMD) Therapeutics Market Expected to Be, and What Will Its Growth Rate Be?
The Duchenne muscular dystrophy (DMD) therapeutics market will grow from $11.95 billion in 2024 to $16.45 billion in 2025, at a CAGR of 37.6%. The growth is attributed to the increasing prevalence of Duchenne muscular dystrophy, rising awareness of treatment options, healthcare spending, and government initiatives.
The Duchenne muscular dystrophy (DMD) therapeutics…
Duchenne Muscular Dystrophy Pipeline Outlook Report 2024
DelveInsight's, "Duchenne Muscular Dystrophy Pipeline Insight 2024" report provides comprehensive insights about 75+ companies and 75+ pipeline drugs in the Duchenne Muscular Dystrophy pipeline landscape. It covers the Duchenne Muscular Dystrophy pipeline drug profiles, including Duchenne Muscular Dystrophy clinical trials and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
…
Duchenne Muscular Dystrophy Treatmcent Market
Global Duchenne Muscular Dystrophy Treatmcent Market Set for Robust Growth During Forecast Period
The global Duchenne Muscular Dystrophy Treatment Market is poised to witness significant growth at a high Compound Annual Growth Rate (CAGR) during the forecast period of 2023 to 2030. Duchenne muscular dystrophy (DMD) stands as a genetic disorder marked by progressive muscle degeneration and weakness, with therapeutics aimed at addressing the absence of dystrophin, a crucial protein in…
Duchenne Muscular Dystrophy (DMD) Drugs Market Report
As per the research conducted by GME, the Duchenne Muscular Dystrophy (DMD) Drugs Market will grow with a CAGR value of 41.3 percent by 2026. The global market for Duchenne muscular dystrophy is foreseen to grow due to accelerated research and development activities, expanded patient awareness for effective treatments, and the launch of new medications Moreover, the disease's increasing prominence is likely to drive the global duchenne muscular dystrophy market…
